{"id":"8d43f3824357","type":"article","url":"https://hartvaat.nl/2016/05/01/katheterablatie-van-af-bij-chronisch-hartfalen-state-of-the-art-en-toekomstpersp/","title":"Katheterablatie van AF bij chronisch hartfalen: state-of-the-art en toekomstperspectieven","title_en":"Catheter ablation of atrial fibrillation in chronic heart failure: state-of-the-art and future perspectives.","category":"atriumfibrilleren","category_label":"Atriumfibrilleren","professions":["cardioloog"],"tags":["acuut-hartfalen","anemie-ckd","bisoprolol","bradycardie","cardiale-resynchronisatie","chronische-nierziekte","hfmref","hfpef","hfref","ivabradine","pathfinder-trial","pulsed-field-ablatie-atriumfibrilleren","vrouwen"],"journal":"Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology","doi":"10.1093/europace/euv368","source_url":"https://doi.org/10.1093/europace/euv368","authors":["Matteo Anselmino","Mario Matta","Davide Castagno","Carla Giustetto","Fiorenzo Gaita"],"significance":6,"published":"2016-05-01","source_date":"2016-05-01","image":"","kennis":["https://hartvaat.nl/kennis/antistolling/doacs-overzicht/","https://hartvaat.nl/kennis/ritmestoornissen/implanteerbare-loop-recorder/"],"congress":"","summary_en":"This comprehensive review of catheter ablation for AF in chronic heart failure summarized the state of the art and future perspectives, covering patient selection, procedural techniques, and the evolving evidence for rhythm control in the HF-AF overlap population.","created":"2026-07-03T10:26:04Z","updated":"2026-07-03T18:38:24Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Uitgebreid overzichtsartikel over de huidige stand van zaken en toekomstperspectieven van katheterablatie voor atriumfibrilleren bij patiënten met chronisch hartfalen. Bespreekt indicaties, technieken en langetermijnresultaten.","abstract_original":"Catheter ablation of atrial fibrillation (AFCA) is a widely recommended treatment for symptomatic atrial fibrillation (AF) patients refractory to pharmacological treatment. Catheter ablation of AF is becoming a therapeutic option also among patients with chronic heart failure (CHF), on top of optimal medical treatment, being this arrhythmia related to a higher risk of death and/or symptom's worsening. In fact, in this setting, clinical evidences are continuously increasing. The present systematic review pools all published experiences concerning AFCA among CHF patients, or patients with structural cardiomyopathies, in order to summarize procedural safety and efficacy in this specific population. Moreover, the effects of AFCA on functional class and quality of life and the different procedural protocols available are discussed. The present work, therefore, attempts to provide an evidence-based clinical perspective to optimize clinical indication and tailor procedural characteristics and endpoints to patients affected by CHF referred for AFCA."}